Trial Profile
A Study to Evaluate the Safety of Intravesical Administration of a Second-generation Ultrasound Contrast Agent Sulfur-hexafluoride for the Diagnosis of Vesicoureteral Reflux in Children
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Sulfur hexafluoride (Primary)
- Indications Vesicoureteral reflux
- Focus Adverse reactions
- 23 Dec 2015 New trial record